Sechrist Industries And Dartmouth's Geisel School Of Medicine Work Together To Bring Hyperbaric Oxygen Therapy To Tanzania

ANAHEIM, Calif., June 26, 2018 -- (Healthcare Sales &Marketing Network) -- Sechrist Industries, Inc. has partnered with Jay Buckey, MD, Professor of Medicine at Dartmouth College's Geisel School of Medicine, to bring Hyperbaric Oxygen Therapy (HBOT) to T... Devices Sechrist Industries, hyperbaric oxygen, hyperbaric therapy, hyperbaric chamber
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news

Related Links:

ConclusionsHBOT is safe and well-tolerated in pediatric and young adult patients with CNS tumors. Clinical and radiographic improvements were observed in over half of patients. Clinical trials are needed to establish safety and efficacy of HBOT as adjunct therapy in pediatric CNS tumors.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
Conditions:   AML;   NHL;   Hodgkin Disease;   All Intervention:   Drug: Hyperbaric oxygen Sponsor:   University of Rochester Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conclusions: Findings from this study support the idea of HBOT as a potential intervention following stroke. PMID: 30402285 [PubMed]
Source: Neurology Research International - Category: Neurology Tags: Neurol Res Int Source Type: research
ConclusionThese results suggest that HBO contributes to elimination of H2O2‐induced long‐lasting cystitis through the repair of chronically inflamed bladder tissue and inhibition of the bladder sensory system.
Source: Neurourology and Urodynamics - Category: Urology & Nephrology Authors: Tags: ORIGINAL BASIC SCIENCE ARTICLE Source Type: research
NHS England has published a service specification for provision of hyperbaric oxygen treatment services.
Source: NHS Networks - Category: UK Health Source Type: news
Publication date: January 2019Source: Biomedicine &Pharmacotherapy, Volume 109Author(s): Kholoud M. El-Shewy, Ahmad Kunbaz, Mohamed M. Gad, Muneer J. Al-Husseini, Anas M. Saad, Yasser M. Sammour, Mohamed M. Abdel-DaimAbstractChronic pain is one of the most common clinical presentations in the primary care settings. In the US, Fibromyalgia (FM) affects about 1–3% of adults and commonly occurs in adults between the ages of 40–50 years. FM causes widespread muscular pain and tenderness with hyperalgesia and allodynia and may be associated with other somatic complaints.Hyperbaric oxygen therapy (HBOT) has been ...
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
Publication date: January 2019Source: Biomedicine &Pharmacotherapy, Volume 109Author(s): Mohammad Yousef Memar, Mina Yekani, Naser Alizadeh, Hossein Bannazadeh BaghiAbstractHyperbaric oxygen therapy (HBOT) is a treatment procedure that involves breathing 100% O2 for a certain time and under a certain pressure. HBOT is commonly administrated as a primary or alternative therapy for different diseases such as infections. In this paper, we reviewed the general aspect of HBOT procedures, the mechanisms of antimicrobial effects and the application in the treatment of infections. Parts of the antimicrobial effects of HBOT are...
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
Abstract Chronic pain is one of the most common clinical presentations in the primary care settings. In the US, Fibromyalgia (FM) affects about 1-3% of adults and commonly occurs in adults between the ages of 40-50 years. FM causes widespread muscular pain and tenderness with hyperalgesia and allodynia and may be associated with other somatic complaints. Hyperbaric oxygen therapy (HBOT) has been utilized and has recently shown promising effects in the management of FM and other chronic pain disorders. In HBOT, the intermittent breathing of 100% oxygen in a pressurized chamber where the pressure is higher than 1 at...
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - Category: Drugs & Pharmacology Authors: Tags: Biomed Pharmacother Source Type: research
Abstract Hyperbaric oxygen therapy (HBOT) is a treatment procedure that involves breathing 100% O2 for a certain time and under a certain pressure. HBOT is commonly administrated as a primary or alternative therapy for different diseases such as infections. In this paper, we reviewed the general aspect of HBOT procedures, the mechanisms of antimicrobial effects and the application in the treatment of infections. Parts of the antimicrobial effects of HBOT are believed to result of reactive from the formation of reactive oxygen species (ROS). It is also said that HBOT enhances the antimicrobial effects of the immune...
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - Category: Drugs & Pharmacology Authors: Tags: Biomed Pharmacother Source Type: research
Publication date: Available online 1 November 2018Source: Neuroscience LettersAuthor(s): Lei Sun, Lin Zhao, Pinpin Li, Xuehua Liu, Fang Liang, Yijia Jiang, Nan Kang, Chunjin Gao, Jing YangAbstractAlthough there are reports of the beneficial effects of hyperbaric oxygen (HBO) therapy in experimental settings, there are few clinical trials of HBO therapy for acute spinal cord injury (SCI). We investigated the effect of HBO in acute SCI by measuring plasma high mobility group box 1 (HMGB1) and nuclear factor kappa-B (NF-κB) levels, and by monitoring changes in electromyogram F-persistence (the percentage of discernible ...
Source: Neuroscience Letters - Category: Neuroscience Source Type: research
More News: Hyperbaric Oxygen Therapy | Marketing | Pharmaceuticals | Tanzania Health